Conference Coverage
Conference Coverage
MS and COVID: Docs switched DMTs but maybe didn’t need to
Switching was rampant early on, a survey finds, but a new study suggests specific drugs don’t boost risk.
Conference Coverage
Immune response detected in most IBD patients after COVID vaccines
Overall, similar levels of antibodies were seen across vaccine type, age group, and medication class, with the exception of corticosteroids.
Conference Coverage
Comorbidities larger factor than race in COVID ICU deaths?
Conference Coverage
Mortality in 2nd wave higher with ECMO for COVID-ARDS
Conference Coverage
ECTRIMS/EAN statement on COVID-19 vaccination in patients with MS
The statement concludes that the COVID-19 vaccines that are currently available are safe for patients with MS.
Conference Coverage
Biomarkers may indicate severity of COVID in children
"A model of six miRNAs was able to discriminate between severe and nonsevere infections with high sensitivity and accuracy in a preliminary...
Conference Coverage
Pandemic survey: Forty-six percent of pediatric headache patients got worse
But some fared better when they were stuck at home instead of at school.
Conference Coverage
COVID-19 vaccination in MS: Lower response on certain medications
Currently approved COVID-19 vaccines appear safe in patients with MS and are effective in most patients.
Conference Coverage
No short-term death risk in elderly after COVID-19 vaccines
Early reports of deaths shortly after mRNA-based vaccination of very frail elderly patients in Norway prompted a nationwide safety study.
Conference Coverage
Omega-3s tame inflammation in elderly COVID-19 patients
Those who received an intravenous infusion had significant decreases from baseline to end of treatment in the neutrophil-to-lymphocyte ratio.